$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Study design
All research procedures involving human participants were conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (IRB) of Chengdu First People's Hospital (Approval ID: CDFPR-2024-GATT-018)9. Written informed consent was obtained from all participants prior to enrollment, detailing the surgical procedure, potential risks, and longitudinal follow-up requirements. The study employs a retrospective cohort design with standardized data collection protocols implemented in November 2018, enabling analysis of consecutive patients through November 2023.
Methods
Data from patients undergoing GATT operations at Chengdu First People's Hospital were collected. The study follows the principles laid down in the Declaration of Helsinki10. All patients were examined at corresponding points before and after surgery, and the relevant observation indicators were recorded.
Patients
The inclusion criteria for this study consisted of patients diagnosed with POAG who required GATT surgery due to uncontrolled IOP despite maximal medical therapy (18 years of age or older). Additionally, patients who were intolerant to glaucoma medication (due to nonadherence or ocular allergy) and those with evidence of progressive glaucoma as determined by visual field examination were included.
The exclusion criteria for this study were as follows: age younger than 18 years, previous ocular surgery or trauma, presence of combined ophthalmologic diseases other than POAG (such as uveitis, cataract, ectopia lentis, aniridia, axial myopia, etc.), presence of PAS as assessed by preoperative microscopy, and irregular follow-up of less than 1 year.
During the preoperative evaluation, detailed ophthalmic examinations were conducted, including assessment of best-corrected visual acuity (BCVA) using a standard Snellen chart, slit-lamp biomicroscopy, gonioscopy, and IOP measurement. Central 24-2 threshold visual field tests were performed using the SITA-Fast strategy with the Humphrey Field OCT. Retinal nerve fiber analysis was conducted using spectral domain optical coherence tomography.
Surgical procedure
All operations were performed by the same experienced ophthalmologist. After standard aseptic disinfection, the operated eye was covered, and the eyelid was fixed with an eyelid retractor. Topical anesthesia was applied to the operated eye. A primary incision was made first at the temporal limbus, and an auxiliary incision directed toward the nasal angle was made superiorly or inferiorly. Lidocaine stock solution, miotic, and high cohesive viscoelastic were injected into the anterior chamber to increase intraocular pressure (approximately 30 mm Hg). This was done to maintain anterior chamber depth and prevent bleeding. Under direct gonioscopy, a goniotomy ranging from 1 to 2 h was performed in the nasal angle with a 25 G microknife to expose the Schlemm's lumen. Then, the microcatheter with a light source is introduced into the anterior chamber through the auxiliary incision and into the Schlemm lumen at an angle of 10–15° under direct gonioscopy, slowly advancing around the lumen for 360°. The right eye is usually counterclockwise, and the left eye is clockwise. In case of resistance, it needs to be retracted and adjusted or another incision is reverse encircled; when the suture or catheter tip is punctured out from the goniotomy, the two ends of the head and tail are clamped with microforceps to pull outwards to form the lasso and tighten, the trabecular meshwork and the inner wall of Schlemm's canal are torn to complete 360 trabeculotomy, and blood reflux from the superficial scleral vein is observed at this time; finally, the device is withdrawn, perfusion aspiration is performed to remove part of the viscoelastic agent but 15%-40% is retained to fill the hemostasis, and the intraocular pressure is adjusted to the first day after surgery target of 15–18 mmHg. Antibiotics, glucocorticoids, and pilocarpine eye drops are routinely used after surgery. Examinations were performed on the first day, the first week, the first month, the third month, the sixth month, and the first year after surgery. Anterior chamber microscopy, intraocular pressure, and use of antiglaucoma medications were recorded at each follow-up visit.
Standard for successful surgery
The success of GATT surgery is divided into two levels11: complete success (without the need for medication, with intraocular pressure ranging from 6 to 18 mmHg and a reduction of ≥20–30% compared to the baseline) and conditional success (achieved with ≤2 types of medication to reach the same intraocular pressure target). Failure is defined as uncontrolled intraocular pressure, the need for another surgery, or the occurrence of serious complications. This study was followed up for 1 year after surgery, and no failures were observed.
Assessment of postoperative PAS formation
Angle morphology was observed and recorded preoperatively, as well as at 3 months, 6 months, and 1 year postoperatively. Following routine ophthalmic examinations, each patient's angle characteristics were assessed using a four-sided gonioscope. To ensure patient comfort, topical anesthetic eye drops (0.5% proparacaine hydrochloride) were instilled on the ocular surface. Levofloxacin gel was then applied to fill the lens concavity. Carefully touching the patient's cornea, the lens was rotated to maintain the eye in the main position. Slit lamp examination and the Spaeth method were employed to observe and record the patient's angle characteristics. Figure 1 provides a representative image of PAS evaluation in this study.
Statistical analysis
All data from participants were analyzed. Non-normal distribution data were presented as median and interquartile range, and grade data and categorical data were presented as frequency and percentage. For the categorical and ordinal data derived from the Spaeth classification (including iris root insertion grade, angle width, and pigment grading) evaluated across multiple time points (preoperatively and at 3, 6, and 12 months postoperatively), the Friedman test was used for overall comparison. When the Friedman test indicated a statistically significant difference, post hoc pairwise comparisons between specific time points were conducted using the Wilcoxon signed-rank test, with a Bonferroni correction to adjust the P-value threshold for multiple comparisons. For repeated-measures binary data (e.g., the presence or absence of specific complications over time), Cochran's Q test was used. All statistical analyses were two-sided, and a P-value < 0.05 (or the Bonferroni-adjusted P-value for post-hoc tests) was considered statistically significant12.